stars 1 stars 2 stars 3

The NOVA Vision Testing System analyzes the entire pathway for visual and neuron-visual disorders.

Website http://diopsys.com/
Revenue $46 million
Funding $350000
Employees 29 (18 on RocketReach)
Founded 1998
Phone +1 973-244-0622
Fax (973) 244-0670
Technologies
Industry Medical Equipment Manufacturing, Manufacturing General, Medical Device, Vision Testing, Manufacturing, Health Care, Electrophysiology, Visual Evoked Potential, Electroretinography, Eye Care, Optometry, Ophthalmology
Web Rank 5 Million
Keywords Eye Care, Eye Disease Detection, Vision Health, Eye Health Technology, Early Detection, Ocular Health, Vision Care Technology, Vision Testing, Clinical Diagnostics, Ophthalmology, Optometry, Diagnostic Tools, Visual Acuity, Patient Management, Healthcare Technology, Medical Technology
Competitors ZEISS Group, Lumenis, Optos, Sight Sciences, Haag-Streit, Nidek Inc., Anka Systems, Object Technology International , Inc., CENTERVUE, INC., INTERNATIONAL JOURNAL OF HYPERTHERMIA +21 more (view full list)
SIC SIC Code 504 Companies, SIC Code 50 Companies
NAICS NAICS Code 33 Companies, NAICS Code 4234 Companies, NAICS Code 42345 Companies, NAICS Code 423 Companies, NAICS Code 42 Companies

Diopsys Questions

The Diopsys annual revenue was $46 million in 2026.

Joseph Fontanetta is the CEO of Diopsys.

18 people are employed at Diopsys.

Diopsys is based in Middletown, Pennsylvania.

The NAICS codes for Diopsys are [33, 4234, 42345, 423, 42].

The SIC codes for Diopsys are [504, 50].

Top Diopsys Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users